These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18719906)

  • 21. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
    van Royen E; Verhoeff NF; Speelman JD; Wolters EC; Kuiper MA; Janssen AG
    Arch Neurol; 1993 May; 50(5):513-6. PubMed ID: 8489409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
    Schwarz J; Antonini A; Tatsch K; Kirsch CM; Oertel WH; Leenders KL
    Nucl Med Commun; 1994 Oct; 15(10):806-13. PubMed ID: 7838444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    Eur Neurol; 2004; 51(1):26-9. PubMed ID: 14631126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal dopamine receptor binding in epileptic psychoses.
    Ring HA; Trimble MR; Costa DC; Moriarty J; Verhoeff NP; Ell PJ
    Biol Psychiatry; 1994 Mar; 35(6):375-80. PubMed ID: 8018783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.
    Oder W; Brücke T; Kollegger H; Spatt J; Asenbaum S; Deecke L
    J Neural Transm (Vienna); 1996; 103(8-9):1093-103. PubMed ID: 9013397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
    Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S; Tauscher J; Küfferle B; Barnas C; Hesselmann B; Asenbaum S; Podreka I; Brücke T
    Psychopharmacology (Berl); 1998 Apr; 136(4):367-73. PubMed ID: 9600582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
    Kishore A; Nygaard TG; de la Fuente-Fernandez R; Naini AB; Schulzer M; Mak E; Ruth TJ; Calne DB; Snow BJ; Stoessl AJ
    Neurology; 1998 Apr; 50(4):1028-32. PubMed ID: 9566390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.
    van der Zwaal EM; de Weijer BA; van de Giessen EM; Janssen I; Berends FJ; van de Laar A; Ackermans MT; Fliers E; la Fleur SE; Booij J; Serlie MJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1190-200. PubMed ID: 27184782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M; Parellada E; Lomeña F; Catafau AM; Font M; Gómez JC; López-Carrero C; Gutiérrez F; Pavía J; Salamero M
    Psychiatry Res; 2001 Aug; 107(2):87-97. PubMed ID: 11530275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the dopaminergic system and depressive symptoms in cervical dystonia.
    Zoons E; Tijssen MAJ; Dreissen YEM; Speelman JD; Smit M; Booij J
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1375-1382. PubMed ID: 28314910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S; Schlösser R; Hiemke C; Nickel O; Bockisch A; Hahn K
    Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
    Catafau AM; Suarez M; Bullich S; Llop J; Nucci G; Gunn RN; Brittain C; Laruelle M;
    Neuroimage; 2009 Jun; 46(2):447-58. PubMed ID: 19233294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study.
    Safont G; Corripio I; Escartí MJ; Portella MJ; Pérez V; Ferrer M; Camacho V; Sauras RB; Alonso A; Grasa EM; Arranz B; San L; Dueñas R; Carrió I; Álvarez E
    Schizophr Res; 2011 Jul; 129(2-3):169-71. PubMed ID: 21459559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
    Barnas C; Quiner S; Tauscher J; Hilger E; Willeit M; Küfferle B; Asenbaum S; Brücke T; Rao ML; Kasper S
    Psychopharmacology (Berl); 2001 Sep; 157(3):236-42. PubMed ID: 11605078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal dopamine D2/D3 receptor availability in male smokers.
    Yang YK; Yao WJ; McEvoy JP; Chu CL; Lee IH; Chen PS; Yeh TL; Chiu NT
    Psychiatry Res; 2006 Jan; 146(1):87-90. PubMed ID: 16343861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontotemporal and striatal SPECT abnormalities in myoclonus-dystonia: phenotypic and pathogenetic considerations.
    Papapetropoulos S; Argyriou AA; Polychronopoulos P; Spyridonidis T; Gourzis P; Chroni E
    Neurodegener Dis; 2008; 5(6):355-8. PubMed ID: 18309231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.